Intra-articular lentivirus-mediated gene therapy targeting CRACM1 for the treatment of collagen-induced arthritis.

[1]  M. Fujii,et al.  Defective splicing of the background K+ channel K2P5.1 by the pre-mRNA splicing inhibitor, pladienolide B in lectin-activated mouse splenic CD4+ T cells. , 2016, Journal of pharmacological sciences.

[2]  M. Kuno,et al.  CRACM3 regulates the stability of non-excitable exocytotic vesicle fusion pores in a Ca2+-independent manner via molecular interaction with syntaxin4 , 2016, Scientific Reports.

[3]  Feng Cai,et al.  Celastrol, an NF-κB inhibitor, ameliorates hypercalciuria and articular cartilage lesions in a mouse model of secondary osteoporosis. , 2016, Journal of pharmacological sciences.

[4]  K. Maeyama,et al.  Systemic Lentivirus-Mediated Delivery of Short Hairpin RNA Targeting Calcium Release–Activated Calcium Channel 3 as Gene Therapy for Collagen-Induced Arthritis , 2015, The Journal of Immunology.

[5]  K. Moudgil,et al.  Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy , 2014, International journal of molecular sciences.

[6]  A. Schambach,et al.  Safety of gene therapy: new insights to a puzzling case. , 2014, Current gene therapy.

[7]  M. Kuno,et al.  Upregulation of store‐operated Ca2+ entry in the naïve CD4+ T cells with aberrant cytokine releasing in active rheumatoid arthritis , 2014, Immunology and cell biology.

[8]  J. Ting,et al.  HIV-1 Infection Induces Interleukin-1β Production via TLR8 Protein-dependent and NLRP3 Inflammasome Mechanisms in Human Monocytes* , 2014, The Journal of Biological Chemistry.

[9]  P. Robbins,et al.  Arthritis gene therapy and its tortuous path into the clinic. , 2013, Translational research : the journal of laboratory and clinical medicine.

[10]  M. Prakriya Store-operated Orai channels: structure and function. , 2013, Current topics in membranes.

[11]  S. Akira,et al.  Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. , 2012, Cell host & microbe.

[12]  David H. Salinger,et al.  A dose–response Meta‐Analysis for Quantifying Relative Efficacy of Biologics in Rheumatoid Arthritis , 2011, Clinical pharmacology and therapeutics.

[13]  R. Rickert,et al.  Magnetic-based purification of untouched mouse germinal center B cells for ex vivo manipulation and biochemical analysis , 2011, Nature Protocols.

[14]  A. Parekh Store-operated CRAC channels: function in health and disease , 2010, Nature Reviews Drug Discovery.

[15]  Ashley M. Miller,et al.  Mast cells express IL-17A in rheumatoid arthritis synovium. , 2010, Journal of immunology.

[16]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[17]  M. Beaven,et al.  Regulation of Ca2+ signaling with particular focus on mast cells. , 2009, Critical reviews in immunology.

[18]  Y. Shimizu,et al.  Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo. , 2008, International immunopharmacology.

[19]  Y. Kadono,et al.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction , 2006, The Journal of experimental medicine.

[20]  J. Kay,et al.  The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. , 2004, Rheumatology.